Intracellular Fate and Impact on Gene Expression of Doxorubicin/Cyclodextrin-Graphene Nanomaterials at Sub-Toxic Concentration

Gelsolin inhibits malignant phenotype of glioblastoma and is regulated by miR‐654‐5p and miR‐450b‐5p

(2020) Jiakang Zhang et al.   CANCER SCIENCE

Systems toxicology assessment revealed the impact of graphene‐based materials on cell cycle regulators

(2020) Masoumeh Farahani et al.   JOURNAL OF BIOMEDICAL MATERIALS RESEARCH PART A

Graphene-Based Strategies in Liquid Biopsy and in Viral Diseases Diagnosis

(2020) Annalaura Cordaro et al.   Nanomaterials

Stimuli-responsive polyvinylpyrrolidone-NIPPAm-lysine graphene oxide nano-hybrid as an anticancer drug delivery on MCF7 cell line

(2019) Maryam Ashjaran et al.   Artificial Cells Nanomedicine and Biotechnology

Oncogenic and Non‐Malignant Pancreatic Exosome Cargo Reveal Distinct Expression of Oncogenic and Prognostic Factors Involved in Tumour Invasion and Metastasis

(2019) Aikaterini Emmanouilidi et al.   PROTEOMICS

Role of RUNX2 transcription factor in epithelial mesenchymal transition in non-small cell lung cancer lung cancer: Epigenetic control of the RUNX2 P1 promoter

(2019) Angélica María Herreño et al.   TUMOR BIOLOGY

TGF-β2 antagonizes IL-6-promoted cell survival

(2019) Yuping Du et al.   MOLECULAR AND CELLULAR BIOCHEMISTRY

Toxicity of Two-Dimensional Layered Materials and Their Heterostructures

(2019) Eveline Tan et al.   BIOCONJUGATE CHEMISTRY

Identification of a six‐gene prognostic signature for oral squamous cell carcinoma

(2019) Jiaying Wang et al.   JOURNAL OF CELLULAR PHYSIOLOGY

SERS Sensing Properties of New Graphene/Gold Nanocomposite

(2019) Giulia Neri et al.   Nanomaterials

Casting Light on Intracellular Tracking of a New Functional Graphene-Based MicroRNA Delivery System by FLIM and Raman Imaging

(2019) Anna Piperno et al.   ACS Applied Materials & Interfaces

Time- and dose-dependent gene expression analysis of macrophage response as a function of porosity of silica nanoparticles

(2019) Mostafa Yazdimamaghani et al.   Nanomedicine-Nanotechnology Biology and Medicine

Exposure to graphene oxide sheets alters the expression of reference genes used for real-time RT-qPCR normalization

(2019) Irene de Lázaro et al.   Scientific Reports

A glance over doxorubicin based-nanotherapeutics: From proof-of-concept studies to solutions in the market

(2019) Mara Gonçalves et al.   JOURNAL OF CONTROLLED RELEASE

Reversing Multidrug Resistance by Multiplexed Gene Silencing for Enhanced Breast Cancer Chemotherapy

(2018) Yanli Li et al.   ACS Applied Materials & Interfaces

Specificity Protein Transcription Factors and Cancer: Opportunities for Drug Development

(2018) Stephen Safe et al.   Cancer Prevention Research

Recent developments in the synthesis and applications of graphene-family materials functionalized with cyclodextrins

(2018) Artur Kasprzak et al.   CHEMICAL COMMUNICATIONS

PRDM4 mediates YAP‐induced cell invasion by activating leukocyte‐specific integrin β2 expression

(2018) Huan Liu et al.   EMBO REPORTS

Doxorubicin and anti-VEGF siRNA co-delivery via nano-graphene oxide for enhanced cancer therapy in vitro and in vivo

(2018) Qi Sun et al.   International Journal of Nanomedicine

Inhibiting pulmonary metastasis of breast cancer based on dual-targeting graphene oxide with high stability and drug loading capacity

(2018) Jing Li et al.   Nanomedicine-Nanotechnology Biology and Medicine

Polyethylene glycol and octa-arginine dual-functionalized nanographene oxide: an optimization for efficient nucleic acid delivery

(2018) Rana Imani et al.   Biomaterials Science

Cellular Signaling Pathways Activated by Functional Graphene Nanomaterials

(2018) Anna Piperno et al.   INTERNATIONAL JOURNAL OF MOLECULAR SCIENCES

Alteration of tumor suppressor BMP5 in sporadic colorectal cancer: a genomic and transcriptomic profiling based study

(2018) Erfei Chen et al.   Molecular Cancer

A genome-wide siRNA screen for regulators of tumor suppressor p53 activity in human non-small cell lung cancer cells identifies components of the RNA splicing machinery as targets for anticancer treatment

(2017) Ellen Siebring-van Olst et al.   Molecular Oncology

Formation of graphene oxide-hybridized nanogels for combinative anticancer therapy

(2017) Xin Xu et al.   Nanomedicine-Nanotechnology Biology and Medicine

TWEAK/Fn14 signaling in tumors

(2017) Guanglei Hu et al.   TUMOR BIOLOGY

Single-cell mass cytometry and transcriptome profiling reveal the impact of graphene on human immune cells

(2017) Marco Orecchioni et al.   Nature Communications

Claudin-3 expression increases the malignant potential of lung adenocarcinoma cells: role of epidermal growth factor receptor activation

(2017) Lianmin Zhang et al.   Oncotarget

Overexpression of NR4A1 is associated with tumor recurrence and poor survival in non-small-cell lung carcinoma

(2017) Bing Zhu et al.   Oncotarget

Inhibition of AKT1 signaling promotes invasion and metastasis of non-small cell lung cancer cells with K-RAS or EGFR mutations

(2017) Guanhua Rao et al.   Scientific Reports

Raman micro spectroscopy for in vitro drug screening: subcellular localisation and interactions of doxorubicin

(2015) Z. Farhane et al.   ANALYST

Engineering of carbon based nanomaterials by ring-opening reactions of a reactive azlactone graphene platform

(2015) G. Neri et al.   CHEMICAL COMMUNICATIONS

Nuclear receptor 4A1 as a drug target for breast cancer chemotherapy

(2015) Erik Hedrick et al.   ENDOCRINE-RELATED CANCER

Repurposing of oxazolone chemistry: gaining access to functionalized graphene nanosheets in a top-down approach from graphite

(2015) Giulia Neri et al.   Chemical Science

Gelsolin regulates proliferation, apoptosis, migration and invasion in human oral carcinoma cells

(2015) RUNZHI DENG et al.   Oncology Letters

Graphene as Cancer Theranostic Tool: Progress and Future Challenges

(2015) Marco Orecchioni et al.   Theranostics

Molecular and Genomic Impact of Large and Small Lateral Dimension Graphene Oxide Sheets on Human Immune Cells from Healthy Donors

(2015) Marco Orecchioni et al.   Advanced Healthcare Materials

CLDN3 inhibits cancer aggressiveness via Wnt-EMT signaling and is a potential prognostic biomarker for hepatocellular carcinoma

(2015) Lei Jiang et al.   Oncotarget

Doxorubicin, DNA torsion, and chromatin dynamics

(2013) Fan Yang et al.   BIOCHIMICA ET BIOPHYSICA ACTA-REVIEWS ON CANCER

Regulation of the Epithelial-Mesenchymal Transition by Claudin-3 and Claudin-4

(2013) Xinjian Lin et al.   PLoS One

Targeting NR4A1 (TR3) in cancer cells and tumors

(2011) Syng-Ook Lee et al.   EXPERT OPINION ON THERAPEUTIC TARGETS

Transforming growth factor beta (TGF-β) and inflammation in cancer

(2009) Brian Bierie et al.   CYTOKINE & GROWTH FACTOR REVIEWS

Urokinase Plasminogen Activator Receptor Choreographs Multiple Ligand Interactions: Implications for Tumor Progression and Therapy

(2008) A. P. Mazar   CLINICAL CANCER RESEARCH